Cows' milk allergy warning over methylprednisolone use

Lactose-containing methylprednisolone preparations should not be used in patients with cows' milk allergy, the MHRA has advised prescribers.

Cows’ milk allergy is an immunological adverse reaction induced by cows’ milk proteins. | iStock.com/Photoevent
Cows’ milk allergy is an immunological adverse reaction induced by cows’ milk proteins. | iStock.com/Photoevent

Serious allergic reactions, including bronchospasm and anaphylaxis, have been reported in patients allergic to cows' milk proteins who were treated with injectable methylprednisolone containing lactose of bovine origin (Solu-Medrone 40mg).

Solu-Medrone 40mg should not be used in patients with a known or suspected allergy to cows' milk. If a patient's symptoms worsen or any new allergic symptoms occur, allergic reaction to cows' milk proteins should be suspected and use of the product should be stopped.

A recent EU review found that patients with cows' milk allergy who experienced allergic reactions to lactose-containing methylprednisolone preparations were generally younger than 12 years and had childhood asthma. In some cases the allergic reaction was misinterpreted as a lack of therapeutic effect, leading to re-administration of methylprednisolone and worsening of the patient's condition.

Solu-Medrone 40mg uses lactose produced from cows' milk as an excipient and may contain trace amounts of milk proteins. The product will be reformulated to remove any trace of milk proteins.

Other strengths of Solu-Medrone and other injectable methylprednisolone products (ie, Depo-Medrone, Depo-Medrone with lidocaine) do not contain milk proteins.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases